FDA Approves Moderna’s mRNA RSV Vaccine — With No Input From Independent Advisers
The FDA said it bypassed input from the agency’s independent advisers because it didn’t see any “concerns or controversial issues.” Moderna is running at least 11 clinical trials for its new mRNA RSV drug...
Recent Comments